Literature DB >> 22473992

Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.

Bokai Zhu1, Combiz Khozoie, Moses T Bility, Christina H Ferry, Nicholas Blazanin, Adam B Glick, Frank J Gonzalez, Jeffrey M Peters.   

Abstract

The role of peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in Harvey sarcoma ras (Hras)-expressing cells was examined. Ligand activation of PPARβ/δ caused a negative selection with respect to cells expressing higher levels of the Hras oncogene by inducing a mitotic block. Mitosis-related genes that are predominantly regulated by E2F were induced to a higher level in HRAS-expressing Pparβ/δ-null keratinocytes compared to HRAS-expressing wild-type keratinocytes. Ligand-activated PPARβ/δ repressed expression of these genes by direct binding with p130/p107, facilitating nuclear translocation and increasing promoter recruitment of p130/p107. These results demonstrate a novel mechanism of PPARβ/δ cross talk with E2F signaling. Since cotreatment with a PPARβ/δ ligand and various mitosis inhibitors increases the efficacy of increasing G₂/M arrest, targeting PPARβ/δ in conjunction with mitosis inhibitors could become a suitable option for development of new multitarget strategies for inhibiting RAS-dependent tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22473992      PMCID: PMC3372236          DOI: 10.1128/MCB.00092-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  70 in total

Review 1.  Molecular networks as sensors and drivers of common human diseases.

Authors:  Eric E Schadt
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

2.  Isolation and utilization of epidermal keratinocytes for oncogene research.

Authors:  A A Dlugosz; A B Glick; T Tennenbaum; W C Weinberg; S H Yuspa
Journal:  Methods Enzymol       Date:  1995       Impact factor: 1.600

3.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Biological function and prognostic significance of peroxisome proliferator-activated receptor δ in rectal cancer.

Authors:  Lie Yang; Hong Zhang; Zong-Guang Zhou; Hui Yan; G Adell; Xiao-Feng Sun
Journal:  Clin Cancer Res       Date:  2011-04-29       Impact factor: 12.531

6.  Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons.

Authors:  D Bizub; A W Wood; A M Skalka
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

7.  B55alpha PP2A holoenzymes modulate the phosphorylation status of the retinoblastoma-related protein p107 and its activation.

Authors:  Girish Jayadeva; Alison Kurimchak; Judit Garriga; Elena Sotillo; Anthony J Davis; Dale S Haines; Marc Mumby; Xavier Graña
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

8.  p25rum1 orders S phase and mitosis by acting as an inhibitor of the p34cdc2 mitotic kinase.

Authors:  J Correa-Bordes; P Nurse
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

9.  A mitosis block links active cell cycle with human epidermal differentiation and results in endoreplication.

Authors:  Jennifer Zanet; Ana Freije; María Ruiz; Vincent Coulon; J Ramón Sanz; Jean Chiesa; Alberto Gandarillas
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

10.  Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis.

Authors:  Moses T Bility; Meghann K Devlin-Durante; Nicholas Blazanin; Adam B Glick; Jerrold M Ward; Boo Hyon Kang; Mary J Kennett; Frank J Gonzalez; Jeffrey M Peters
Journal:  Carcinogenesis       Date:  2008-09-17       Impact factor: 4.741

View more
  12 in total

1.  Modulation of aryl hydrocarbon receptor (AHR)-dependent signaling by peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in keratinocytes.

Authors:  Michael G Borland; Prasad Krishnan; Christina Lee; Prajakta P Albrecht; Weiwei Shan; Moses T Bility; Craig B Marcus; Jyh M Lin; Shantu Amin; Frank J Gonzalez; Gary H Perdew; Jeffrey M Peters
Journal:  Carcinogenesis       Date:  2014-03-17       Impact factor: 4.944

Review 2.  Regulatory mechanisms mediated by peroxisome proliferator-activated receptor-β/δ in skin cancer.

Authors:  Jeffrey M Peters; Dae J Kim; Moses T Bility; Michael G Borland; Bokai Zhu; Frank J Gonzalez
Journal:  Mol Carcinog       Date:  2019-05-06       Impact factor: 4.784

3.  Inhibition of tumorigenesis by peroxisome proliferator-activated receptor (PPAR)-dependent cell cycle blocks in human skin carcinoma cells.

Authors:  Michael G Borland; Ellen M Kehres; Christina Lee; Ashley L Wagner; Brooke E Shannon; Prajakta P Albrecht; Bokai Zhu; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2018-05-03       Impact factor: 4.221

4.  The nuclear receptor peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) promotes oncogene-induced cellular senescence through repression of endoplasmic reticulum stress.

Authors:  Bokai Zhu; Christina H Ferry; Lauren K Markell; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2014-06-04       Impact factor: 5.157

5.  Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis.

Authors:  Michael G Borland; Pei-Li Yao; Ellen M Kehres; Christina Lee; Amanda M Pritzlaff; Elizabeth Ola; Ashley L Wagner; Brooke E Shannon; Prajakta P Albrecht; Bokai Zhu; Boo-Hyon Kang; Gavin P Robertson; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2017-10-01       Impact factor: 4.849

Review 6.  Establishing the Role of PPARβ/δ in Carcinogenesis.

Authors:  Jeffrey M Peters; Frank J Gonzalez; Rolf Müller
Journal:  Trends Endocrinol Metab       Date:  2015-10-18       Impact factor: 12.015

Review 7.  Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.

Authors:  Greta M P Giordano Attianese; Béatrice Desvergne
Journal:  Nucl Recept Signal       Date:  2015-04-27

8.  Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.

Authors:  Combiz Khozoie; Michael G Borland; Bokai Zhu; Songjoon Baek; Sam John; Gordon L Hager; Yatrik M Shah; Frank J Gonzalez; Jeffrey M Peters
Journal:  BMC Genomics       Date:  2012-11-24       Impact factor: 3.969

9.  Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.

Authors:  Gayathri Balandaram; Lance R Kramer; Boo-Hyon Kang; Iain A Murray; Gary H Perdew; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicology       Date:  2016-07-15       Impact factor: 4.571

10.  PPARβ/δ promotes HRAS-induced senescence and tumor suppression by potentiating p-ERK and repressing p-AKT signaling.

Authors:  B Zhu; C H Ferry; N Blazanin; M T Bility; C Khozoie; B-H Kang; A B Glick; F J Gonzalez; J M Peters
Journal:  Oncogene       Date:  2013-11-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.